Eargo to Report Fourth Quarter 2022 Financial Results on March 23, 2023

Rhea-AI Summary

Eargo, Inc. (Nasdaq: EAR) will release its fourth quarter 2022 financial results on March 23, 2023, after market close. The company will hold a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss these results and recent highlights. Interested parties can join the call via telephone or the company's website, with a replay available after the event. Eargo is focused on improving hearing health with innovative, affordable, FDA-regulated hearing aids that are virtually invisible and rechargeable, addressing challenges in hearing aid adoption.

Positive

• Eargo's innovative hearing aids are offered at about half the cost of traditional options.
• The Eargo 7 is FDA 510(k) cleared and features advanced technology for user comfort.
• Direct access to hearing professionals through multiple channels enhances customer service.

Negative

• None.

SAN JOSE, Calif., March 17, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the fourth quarter 2022 after market close on March 23, 2023. On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers, using conference ID: 2951533. The live webinar of the call may also be accessed by visiting the Events and Presentations section of Eargo’s website at ir.eargo.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on Eargo’s website for one year.

About Eargo
Eargo is a medical device company on a mission to improve hearing health. Our innovative products and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first virtually invisible, rechargeable, completely-in-canal, FDA-regulated devices indicated to compensate for mild to moderate hearing loss. Our differentiated, consumer-first approach empowers consumers to take control of their hearing. Consumers can purchase online, at retail locations or over the phone and get personalized and convenient consultation and support from hearing professionals via phone, text, email or video chat. Eargo hearing aids are offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States.

Eargo’s seventh generation device, Eargo 7, is an FDA 510(k) cleared, self-fitting over-the-counter hearing aid featuring Sound Adjust+ with Comfort and Clarity Modes, which focuses on noise reduction and adapting to the user’s environment and needs.

Related Links
http://eargo.com

Investor Contact
Nick Laudico
Chief Retail Officer
ir@eargo.com 

FAQ

When will Eargo announce its fourth quarter 2022 financial results?

Eargo will announce its fourth quarter 2022 financial results on March 23, 2023.

What time will Eargo's conference call be held?

Eargo's conference call will be held at 1:30 p.m. PT (4:30 p.m. ET) on March 23, 2023.

How can I access the Eargo conference call?

You can access the Eargo conference call via telephone or by visiting the Events and Presentations section of Eargo’s website.

What features does the Eargo 7 hearing aid have?

The Eargo 7 has Sound Adjust+ for noise reduction and adapts to the user’s environment.

How does Eargo address traditional hearing aid challenges?

Eargo offers virtually invisible, rechargeable, and affordable hearing aids, targeting social stigma and accessibility issues.